Bold Capital Partners — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
Erie, US
Board seatLindsay Karas-Stencel· per SEC Form D · $2M raise · filed Jan 2022
Santa Monica, US
Tony Robbins(Director)Dugal Bain-Kim(Director)Joel Jackson(Director)Brian Carroll(Executive Officer)
BoardCourtney Reum(Director)
Board seatPeter Diamandis· per SEC Form D · $6M raise · filed Feb 2022
Travel & HospitalityOpa Locka, US
Richard Lawrence Kane(Executive Officer, Director)Steven Clements(Executive Officer)Stephen M. Wagman(Executive Officer)Erik R. Lindbergh(Director)David H. Treitel(Director)Gene Valentino(Director)
Board seatPeter Diamandis· per SEC Form D · $60M raise · filed Mar 2022
Form Bio develops AI-driven software and bioinformatics tools for genetic medicine and genome engineering, enabling faster and safer design of gene therapies, protein engineering, and manufacturing optimization.
AI & Machine LearningBiotechDeep TechAustin, US
Benjamin Lamm(Director, Promoter)Andrew Busey(Executive Officer, Director, Promoter)Michelle Chen, PhDDoug DanielsJoe Nipko, PhDAmicia Elliott, PhD
Co-investorsBreyer CapitalCarnrite VenturesDraper AssociatesJAZZ Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.